Connecting Audio and Radio Sensing Systems to Improve Care at Home

UNC Lineberger Comprehensive Cancer Center13 enrolled

Overview

This study aims to assess the usability of the innovative Audio + Radio (AURA) system in enhancing personalized supportive care for cancer patients and caregivers during the post-ostomy care transition by collecting information on patient's daily activities and answers to survey questionnaire, and enabling access to this information through a voice assistant device.

The investigators will assign up to 30 cancer patients with newly created ostomies for cancer treatment with curative intent and their primary caregivers to the AURA or usual care groups (up to 30 patient-caregiver dyads, a total of 60 individuals). AURA is defined as a system that connects audio-based voice assistant devices with radiofrequency (RF) sensing technology to gather relevant patient information automatically, interactively, and with context-awareness and to store a patient's health records that otherwise had to be measured and entered manually into an electronic system. Additionally, the system enables user's access to this information through a voice assistant device. The users of this system will be the entire care team, consisting of the patient and their family members as well as the caregivers and healthcare providers at remote sites. If results indicate that the pilot trial is feasible, the investigators will design and conduct a definitive trial to examine the efficacy of AURA, a potentially scalable intervention that can be disseminated through oncology clinics nationwide to enhance post-treatment care for cancer patients with ostomies who transition from hospital professional care to self-management at home and their caregivers.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Colorectal Cancer Bladder Cancer Ovarian Cancer Cervical Cancer Uterine Cancer

Interventions

Audio + Radio (AURA)BEHAVIORAL

Participants will receive personalized self-care information based on their symptoms and signs of complications (e.g., fatigue) from interacting with our voice assistant device, connected to a system that integrating the patient-reported outcome and objective data from passive RF sensing to provide continuous monitoring of patients' symptoms and complications after they are discharged home.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria Phase I: The investigators will only be recruiting patients for this phase Patients must: * have been surgically treated for colorectal or bladder cancer with curative intent; * have had an ostomy with curative intent for at least 90 days; * be able to read and speak English; * be 18 years or older; Phase II: The investigators will be recruiting patients and caregivers as a dyad for this phase * Patients must: * have been surgically treated for colorectal or bladder cancer with curative intent; * be within one month of hospital discharge of a newly created ostomy with curative intent; * be able to read and speak English; * be 18 years or older; * have a caregiver who is willing to participate in the study; * Caregivers must: * be 18 years or older; * be able to read and speak English; * be identified as the primary caregiver by the patient; * have not themselves been diagnosed with cancer or received cancer treatment during the study (to ensure that patients and caregivers focus their efforts on care of the patient). Exclusion Criteria Patients and their caregivers will be excluded if they: * are unable to read, speak, or understand English; * have more than one type of ostomy; * have other cancer diagnosis (excluding non-melanomatous skin cancer); or * have cognitive impairment (assessed by the Short Portable Mental Status Questionnaire).

Locations (2)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States

UT Health San Antonio MD Anderson Cancer Center

San Antonio, Texas, United States

Outcomes

Primary Outcomes

Satisfaction with the AURA system

Satisfaction with the AURA system will be assessed by the 9-item Participant Satisfaction Scale measuring the level of program satisfaction ranging from 1=not satisfied to 5=extremely satisfied. Higher total score indicates greater program satisfaction.

Time frame: 1-month followup survey

Perceived ease of use of the PRISMS program

Perceived ease of use of the AURA system will be assessed by the 23-item Usability Scale measuring the ease of use in three aspects: general, content, and navigation. The scales range from 1=strongly disagree to 5=strongly agree. Higher total score indicates greater ease of use.

Time frame: 1-month followup survey

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.